Literature DB >> 25780282

Mesopancreas: A boundless structure, namely the rationale for dissection of the paraaortic area in pancreaticoduodenectomy for pancreatic head carcinoma.

Nadia Peparini1.   

Abstract

This review highlights the rationale for dissection of the 16a2 and 16b1 paraaortic area during pancreaticoduodenectomy (PD) for carcinoma of the head of the pancreas. Recent advances in surgical anatomy of the mesopancreas indicate that the retropancreatic area is not a single entity with well defined boundaries but an anatomical site of embryological fusion of peritoneal layers, and that continuity exists between the neuro lymphovascular adipose tissues of the retropancreatic and paraaortic areas. Recent advances in surgical pathology and oncology indicate that, in pancreatic head carcinoma, the mesopancreatic resection margin is the primary site for R1 resection, and that epithelial-mesenchymal transition-related processes involved in tumor progression may impact on the prevalence of R1 resection or local recurrence rates after R0 surgery. These concepts imply that mesopancreas resection during PD for pancreatic head carcinoma should be extended to the paraaortic area in order to maximize retropancreatic clearance and minimize the likelihood of an R1 resection or the persistence of residual tumor cells after R0 resection. In PD for pancreatic head carcinoma, the rationale for dissection of the paraaortic area is to control the spread of the tumor cells along the mesopancreatic resection margin, rather than to control or stage the nodal spread. Although mesopancreatic resection cannot be considered "complete" or "en bloc", it should be "extended as far as possible" or be "maximal", including dissection of 16a2 and 16b1 paraaortic areas.

Entities:  

Keywords:  Mesopancreas; Mesopancreas resection; Pancreatic carcinoma; Paraaortic area; Paraaortic dissection

Mesh:

Year:  2015        PMID: 25780282      PMCID: PMC4356904          DOI: 10.3748/wjg.v21.i10.2865

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  57 in total

1.  Mesopancreas: myth or reality?

Authors:  Manish K Agrawal; Dilip Singh Thakur; Uday Somashekar; Shiv Kumar Chandrakar; Dhananjaya Sharma
Journal:  JOP       Date:  2010-05-05

2.  Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Yoshio Yuasa; Taijiro Sueda
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

3.  Appraisal of a total meso-pancreatoduodenum excision with pancreaticoduodenectomy for pancreatic head carcinoma.

Authors:  Y Kawabata; T Tanaka; T Nishi; H Monma; S Yano; Y Tajima
Journal:  Eur J Surg Oncol       Date:  2012-05-09       Impact factor: 4.424

4.  Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma.

Authors:  Kazuaki Shimada; Tsuyoshi Sano; Yoshihiro Sakamoto; Tomoo Kosuge
Journal:  Ann Surg Oncol       Date:  2006-12       Impact factor: 5.344

5.  Tumour growth is more dispersed in pancreatic head cancers than in rectal cancer: implications for resection margin assessment.

Authors:  Caroline Sophie Verbeke; Johannes Knapp; Ivar Prydz Gladhaug
Journal:  Histopathology       Date:  2011-12       Impact factor: 5.087

6.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.

Authors:  S Pedrazzoli; V DiCarlo; R Dionigi; F Mosca; P Pederzoli; C Pasquali; G Klöppel; K Dhaene; F Michelassi
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

7.  Radical pancreatoduodenectomy combined with retroperitoneal nerve, lymph, and soft-tissue dissection in pancreatic head cancer.

Authors:  Qin-shu Shao; Zai-yuan Ye; Shu-guang Li; Kan Chen
Journal:  Chin Med J (Engl)       Date:  2008-06-20       Impact factor: 2.628

8.  Tumor deposits are encountered in advanced colorectal cancer and other adenocarcinomas: an expanded classification with implications for colorectal cancer staging system including a unifying concept of in-transit metastases.

Authors:  Giacomo Puppa; Hideki Ueno; Masato Kayahara; Paola Capelli; Vincenzo Canzonieri; Romano Colombari; Patrick Maisonneuve; Giuseppe Pelosi
Journal:  Mod Pathol       Date:  2009-01-09       Impact factor: 7.842

9.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.

Authors:  Charles J Yeo; John L Cameron; Keith D Lillemoe; Taylor A Sohn; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Ralph H Hruban
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

10.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival.

Authors:  Taylor S Riall; John L Cameron; Keith D Lillemoe; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Daniel Laheru; Ralph H Hruban; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

View more
  6 in total

Review 1.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

2.  Para-Aortic Dissection in Pancreaticoduodenectomy with Mesopancreas Excision for Pancreatic Head Carcinoma: Not Only an N-Staging Matter.

Authors:  Nadia Peparini
Journal:  J Gastrointest Surg       Date:  2016-03-21       Impact factor: 3.452

3.  Systematic review of the mesopancreas: concept and clinical implications.

Authors:  J M Ramia; R De-la-Plaza; A Manuel-Vazquez; A Lopez-Marcano; R Morales
Journal:  Clin Transl Oncol       Date:  2018-04-19       Impact factor: 3.405

4.  Follow "the superior mesenteric artery": laparoscopic approach for total mesopancreas excision during pancreaticoduodenectomy.

Authors:  Edouardo Morales; Giuseppe Zimmitti; Claudio Codignola; Alberto Manzoni; Marco Garatti; Valentina Sega; Edoardo Rosso
Journal:  Surg Endosc       Date:  2019-07-22       Impact factor: 4.584

Review 5.  What do surgeons need to know about the mesopancreas.

Authors:  Eduardo de Souza M Fernandes; Oliver Strobel; Camila Girão; Jose Maria A Moraes-Junior; Orlando Jorge M Torres
Journal:  Langenbecks Arch Surg       Date:  2021-06-12       Impact factor: 3.445

6.  Mesopancreatic Stromal Clearance Defines Curative Resection of Pancreatic Head Cancer and Can Be Predicted Preoperatively by Radiologic Parameters: A Retrospective Study.

Authors:  Ulrich F Wellner; Tobias Krauss; Agnes Csanadi; Hryhoriy Lapshyn; Louisa Bolm; Sylvia Timme; Birte Kulemann; Jens Hoeppner; Simon Kuesters; Gabriel Seifert; Dirk Bausch; Oliver Schilling; Yogesh K Vashist; Thomas Bruckner; Mathias Langer; Frank Makowiec; Ulrich T Hopt; Martin Werner; Tobias Keck; Peter Bronsert
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.